Association of Zidovudine or Nevirapine Treatment with Sperm Abnormalities Across Two Generations of Albino Mice

Authors

  • Chika K. Onwuamah Department of Microbiology, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria
  • Oliver C. Ezechi Department of Clinical Sciences, Nigerian Institute of Medical Research, Lagos, Nigeria
  • Judith O. Sokei Department of Microbiology, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria
  • Chinenye Angela Ogbu Department of Microbiology, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria
  • Peter G. C. Odeigah Department of Cell Biology & Genetics, University of Lagos, Nigeria

DOI:

https://doi.org/10.21106/IJTMRPH_49_2025

Keywords:

  • Albino Mice,
  • Antiretroviral,
  • Human Immunodeficiency Virus,
  • Nevirapine,
  • Oligospermia,
  • Parental and F1 Generation,
  • Sperm,
  • Zidovudine

Abstract

Background and Objective: The long-term use of antiretroviral drugs has raised concerns beyond improvements in the quality of life of people living with HIV (PLWH), including reproductive challenges among PLWH. Many PLWH desire to have children, but human immunodeficiency virus (HIV) infection and/or antiretroviral therapy may hinder this possibility. This study sought to evaluate the influence of zidovudine [ZDV] or nevirapine [NVP] on the sperm and testes of albino mice across two generations.

Methods: ZDV (10, 100, and 250 mg/kg) and NVP (5, 50, and 150 mg/kg) were administered through gavage throughout one spermatogenic cycle to the parental generation of mice. Testicular weight, sperm counts, sperm head anomalies, and sperm deoxyribonucleic acid (DNA) quantity were determined for the treatment and control groups. Hemocytometry and microscopy were used to determine sperm counts and sperm head anomalies. Fluorometric evaluations of picogreen-labeled DNA were used to determine the quantity of sperm DNA.

Results: Among the parental generation, sperm counts were significantly reduced among all treatment groups, but changes in sperm DNA quantity were not significantly different. Among the F1 groups, there were significant reductions in testicular weight, sperm counts, and sperm DNA quantity. Changes in sperm head morphology appeared transient among the parental generation and were not significantly different among the F1 generation.

Conclusion and Implications for Translation: Administration of ZDV or NVP to mice resulted in significant oligospermia in both the parental and F1 groups. Across both generations, ZDV affected sperm DNA quantity, sperm counts, and sperm morphology, while NVP mainly impacted sperm DNA quantity. The transgenerational effect observed calls for monitoring among HIV-positive adolescents on lifelong treatment for possible adverse effects on male reproductive health.

Downloads

Download data is not yet available.

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Abstract Views: 2063
PDF Views/Downloads: 919
HTML Views/Downloads: 197
XML Views/Downloads: 38
Epub Views/Downloads: 748

Published

2026-01-29
Dimensions Citation count:

How to Cite

Onwuamah, C. K., Ezechi, O. C., Sokei, J. O., Ogbu, C. A., & Odeigah, P. G. C. (2026). Association of Zidovudine or Nevirapine Treatment with Sperm Abnormalities Across Two Generations of Albino Mice . International Journal of Translational Medical Research and Public Health, 10(1), e003. https://doi.org/10.21106/IJTMRPH_49_2025

License


Copyright © 2026 Chika K. Onwuamah, Oliver C. Ezechi, Judith O. Sokei, Chinenye Angela Ogbu, Peter G. C. Odeigah. Published by Global Health and Education Projects, Inc., USA.

Creative Commons License

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License , which permits others to remix, transform, and build upon the work non-commercially, provided the original author is credited and the new creations are licensed under the same terms.